|
Gordon Christopher R
|
Non-Executive Director |
Cerevel Therapeutics Holdings, Inc. (CERE)
|
2023-10-16 |
$22.81 |
97.1% |
$121,383,146
|
5,480,052
|
$124,999,986 |
|
Bain Capital Investors Llc
|
Non-Executive |
Cerevel Therapeutics Holdings, Inc. (CERE)
|
2023-10-16 |
$22.81 |
97.1% |
$121,383,146
|
5,480,052
|
$124,999,986 |
|
Koppel Adam
|
Non-Executive Director |
Cerevel Therapeutics Holdings, Inc. (CERE)
|
2023-10-16 |
$22.81 |
97.1% |
$121,383,146
|
5,480,052
|
$124,999,986 |
|
Duggan Robert W
|
Non-Executive Director |
Pulse Biosciences, Inc. (PLSE)
|
2023-05-09 |
$6.51 |
168.5% |
$109,951,619
|
10,022,937
|
$65,249,320 |
|
Cormorant Asset Management, Lp
|
Non-Executive |
Ambrx Biopharma Inc. (AMAM)
|
2023-04-20 |
$11.30 |
147.7% |
$87,074,602
|
5,215,189
|
$58,950,690 |
|
Mfn Partners, Lp
|
Non-Executive |
RXO, Inc. (RXO)
|
2024-08-12 |
$20.21 |
34.9% |
$72,381,011
|
10,266,810
|
$207,492,230 |
|
Sarofim Christopher Binyon
|
Non-Executive Director |
Sable Offshore Corp. (SOC)
|
2024-02-14 |
$10.00 |
116.1% |
$69,660,006
|
6,000,000
|
$60,000,000 |
|
Viking Global Investors Lp
|
Non-Executive |
RayzeBio, Inc. (RYZB)
|
2023-09-19 |
$18.00 |
247.2% |
$61,791,674
|
1,388,889
|
$25,000,002 |
|
Viking Global Investors Lp
|
Non-Executive |
RayzeBio, Inc. (RYZB)
|
2023-09-19 |
$18.00 |
247.2% |
$61,791,674
|
1,388,889
|
$25,000,002 |
|
Loews Corp
|
Non-Executive |
CNA FINANCIAL CORP (CNA)
|
2023-08-02 |
$39.29 |
30.4% |
$53,249,806
|
4,456,050
|
$175,078,204 |
|
Ra Capital Management, L.P.
|
Non-Executive Director |
Eliem Therapeutics, Inc. (ELYM)
|
2024-06-27 |
$3.84 |
97.1% |
$48,521,877
|
13,008,546
|
$49,952,817 |
|
Whitesell Patrick
|
Non-Executive |
TKO Group Holdings, Inc. (TKO)
|
2024-04-09 |
$89.01 |
30.5% |
$44,655,928
|
1,642,970
|
$146,240,760 |
|
Emanuel Ariel
|
Chief Executive Officer |
TKO Group Holdings, Inc. (TKO)
|
2024-04-09 |
$89.01 |
30.5% |
$44,655,928
|
1,642,970
|
$146,240,760 |
|
White Mountains Insurance Group Ltd
|
Non-Executive Director |
MediaAlpha, Inc. (MAX)
|
2023-06-30 |
$10.00 |
72.6% |
$42,956,084
|
5,916,816
|
$59,168,160 |
|
Cormorant Asset Management, Lp
|
Non-Executive |
Ambrx Biopharma Inc. (AMAM)
|
2023-09-18 |
$9.12 |
207.1% |
$40,651,063
|
2,152,738
|
$19,625,601 |
|
Telegraph Hill Partners Iv, L.P.
|
Non-Executive |
Alpha Teknova, Inc. (TKNO)
|
2024-07-12 |
$1.24 |
269.4% |
$40,403,222
|
12,096,773
|
$14,999,999 |
|
Flores James C
|
Chairman |
Sable Offshore Corp. (SOC)
|
2024-02-14 |
$10.01 |
115.9% |
$37,330,123
|
3,217,500
|
$32,200,055 |
|
Lantheus Alpha Therapy, Llc
|
Non-Executive |
Perspective Therapeutics, Inc. (CATX)
|
2024-03-06 |
$9.50 |
62.5% |
$35,896,037
|
6,043,104
|
$57,409,487 |
|
Stonehill Capital Management Llc
|
Non-Executive |
Veradigm Inc. (MDRX)
|
2024-03-01 |
$6.46 |
54.1% |
$35,716,106
|
10,222,875
|
$66,001,500 |
|
Avalon Ventures Xi, L.P.
|
Non-Executive |
Janux Therapeutics, Inc. (JANX)
|
2023-11-13 |
$5.87 |
644.6% |
$32,158,475
|
849,854
|
$4,988,643 |
|
Reardon Tighe
|
Acting Chief Financial Officer |
Janux Therapeutics, Inc. (JANX)
|
2023-11-13 |
$5.87 |
644.6% |
$32,158,475
|
849,854
|
$4,988,643 |
|
Lichter Jay
|
Non-Executive Director |
Janux Therapeutics, Inc. (JANX)
|
2023-11-13 |
$5.87 |
644.6% |
$32,158,475
|
849,854
|
$4,988,643 |
|
Sylebra Capital Ltd
|
Non-Executive |
IMPINJ INC (PI)
|
2023-08-11 |
$58.26 |
183.6% |
$28,209,631
|
263,740
|
$15,365,492 |
|
Perceptive Advisors Llc
|
Non-Executive |
SOLENO THERAPEUTICS INC (SLNO)
|
2023-09-28 |
$17.44 |
186.3% |
$28,151,858
|
866,789
|
$15,113,916 |
|
Kersten Dirk
|
Non-Executive Director |
Dyne Therapeutics, Inc. (DYN)
|
2024-01-09 |
$17.50 |
92.3% |
$27,685,706
|
1,714,285
|
$29,999,988 |
|
Cormorant Asset Management, Lp
|
Non-Executive |
Ambrx Biopharma, Inc. (AMAM)
|
2023-10-23 |
$6.99 |
300.5% |
$27,465,166
|
1,307,311
|
$9,139,542 |
|
Uber Technologies, Inc
|
Non-Executive |
Aurora Innovation, Inc. (AUR)
|
2023-07-21 |
$3.00 |
35.2% |
$26,399,999
|
25,037,036
|
$74,999,997 |
|
Cormorant Asset Management, Lp
|
Non-Executive |
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
|
2024-02-02 |
$19.00 |
167.2% |
$23,827,500
|
750,000
|
$14,250,000 |
|
Dejoria John Paul
|
Non-Executive |
HighPeak Energy, Inc. (HPK)
|
2023-07-19 |
$10.50 |
34.0% |
$23,459,998
|
6,571,428
|
$68,999,994 |
|
Sylebra Capital Ltd
|
Non-Executive |
IMPINJ INC (PI)
|
2023-08-15 |
$61.20 |
170.0% |
$23,423,432
|
225,182
|
$13,781,138 |
|
Telegraph Hill Partners Iv, L.P.
|
Non-Executive |
Alpha Teknova, Inc. (TKNO)
|
2023-09-19 |
$1.85 |
147.6% |
$22,135,132
|
8,108,107
|
$14,999,998 |
|
Blue Star Exploration Corp
|
Non-Executive |
COMSTOCK RESOURCES INC (CRK)
|
2024-03-25 |
$8.04 |
20.8% |
$20,925,000
|
12,500,000
|
$100,450,000 |
|
Sylebra Capital Ltd
|
Non-Executive |
IMPINJ INC (PI)
|
2023-08-16 |
$60.02 |
175.3% |
$20,047,859
|
190,569
|
$11,437,951 |
|
Cui Xiangmin
|
Non-Executive Director |
ALPINE IMMUNE SCIENCES, INC. (ALPN)
|
2023-11-09 |
$12.50 |
419.8% |
$19,676,250
|
375,000
|
$4,687,500 |
|
Decheng Capital Global Healthcare Fund (Master), Lp
|
Non-Executive |
ALPINE IMMUNE SCIENCES, INC. (ALPN)
|
2023-11-09 |
$12.50 |
419.8% |
$19,676,250
|
375,000
|
$4,687,500 |
|
5Am Partners Vii, Llc
|
Non-Executive |
Skye Bioscience, Inc. (SKYE)
|
2024-01-31 |
$2.31 |
162.3% |
$19,522,778
|
5,206,074
|
$12,026,031 |
|
Levinson Sam
|
Non-Executive |
SONIDA SENIOR LIVING, INC. (SNDA)
|
2024-02-01 |
$9.50 |
192.2% |
$19,221,060
|
1,052,632
|
$10,000,004 |
|
Corvex Management Lp
|
Non-Executive |
Vestis Corp (VSTS)
|
2024-05-08 |
$9.96 |
53.5% |
$18,377,671
|
3,446,655
|
$34,321,684 |
|
Katmandu Ventures, Llc
|
Non-Executive |
Falcon's Beyond Global, Inc. (FBYD)
|
2024-06-14 |
$3.02 |
257.2% |
$16,247,227
|
2,095,087
|
$6,316,862 |
|
Ra Capital Management, L.P.
|
Non-Executive Director |
Janux Therapeutics, Inc. (JANX)
|
2023-07-19 |
$12.46 |
250.8% |
$15,469,000
|
495,008
|
$6,167,800 |
|
Eli Lilly & Co
|
Non-Executive |
Sigilon Therapeutics, Inc. (SGTX)
|
2023-08-11 |
$14.92 |
50.6% |
$12,974,620
|
1,718,493
|
$25,639,916 |
|
Jana Partners Management, Lp
|
Non-Executive Director |
MERCURY SYSTEMS INC (MRCY)
|
2024-02-09 |
$27.90 |
34.7% |
$12,931,011
|
1,335,848
|
$37,270,159 |
|
Sylebra Capital Ltd
|
Non-Executive |
IMPINJ INC (PI)
|
2023-08-30 |
$63.32 |
160.9% |
$12,882,911
|
126,427
|
$8,005,358 |
|
Springer Timothy A
|
Non-Executive Director |
Morphic Holding, Inc. (MORF)
|
2023-05-03 |
$45.00 |
26.6% |
$12,589,502
|
1,050,000
|
$47,250,000 |
|
Casdin Partners Master Fund, L.P.
|
Non-Executive |
BIOLIFE SOLUTIONS INC (BLFS)
|
2023-10-19 |
$11.19 |
121.0% |
$12,553,814
|
927,165
|
$10,374,976 |
|
Sc Us (Ttgp), Ltd.
|
Non-Executive |
Maplebear Inc. (CART)
|
2024-02-22 |
$28.54 |
21.3% |
$12,286,139
|
2,020,273
|
$57,655,710 |
|
Gupta Ravi
|
Non-Executive Director |
Maplebear Inc. (CART)
|
2024-02-22 |
$28.54 |
21.3% |
$12,286,139
|
2,020,273
|
$57,655,710 |
|
Sc Us (Ttgp), Ltd.
|
Non-Executive |
Maplebear Inc. (CART)
|
2024-02-22 |
$28.54 |
21.3% |
$12,286,139
|
2,020,273
|
$57,655,710 |
|
Sc Us (Ttgp), Ltd.
|
Non-Executive |
Maplebear Inc. (CART)
|
2024-02-22 |
$28.54 |
21.3% |
$12,286,139
|
2,020,273
|
$57,655,710 |
|
Ecor1 Capital, Llc
|
Non-Executive |
Zymeworks Inc. (ZYME)
|
2023-06-16 |
$8.12 |
44.8% |
$12,194,000
|
3,350,000
|
$27,202,000 |